This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Research » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

The Latest on Vitamin D: Is More Better?

Posted: Saturday, June 25, 2011

Does vitamin D really help to prevent type 2 diabetes? Does having a deficiency lead to complications? The latest research on this topic seems to suggest the answer may be "yes" to both of these questions.

Possible New Treatment for Prediabetic Patients

Posted: Saturday, June 11, 2011

A natural product called DLPC (dilauroyl phosphatidylcholine) increases sensitivity to insulin and reduces fatty liver.

HbA1C Test Poorly Predictive in Dialysis Patients

Posted: Saturday, June 11, 2011

Conventional glucose control monitoring methods may not be as meaningful in diabetes patients with end-stage renal disease, researchers found. Patients on dialysis will normally show a lower A1c than they actually have, giving patients and physicians a false sense of security.

Young Diabetes Patients Using Oral Antidiabetics and Insulin at Higher Risk of Depression

Posted: Sunday, June 05, 2011

The risk of depression among patients with diabetes varies depending on age and type of diabetes according to new research.

Combining Paxil and Pravachol Can Raise Blood Sugar

Posted: Sunday, June 05, 2011

Combining two drugs commonly prescribed to treat depression and lower cholesterol can raise blood sugar to potentially harmful levels, according to a study released this week that was based partly on a search of computerized patient records at Boston-area hospitals.

Diabetes Drug Victoza Could Combat Dementia

Posted: Sunday, June 05, 2011

Dr. Christian Holscher and his University of Ulster, Northern Ireland, UK, team have already found the drug can enhance brain cell growth and protect memory formation in mice, as well as reducing levels of amyloid -- a hallmark protein in Alzheimer's -- in the brain.

Low-Dose Aspirin Helps Heart Only in Some Diabetes Patients

Posted: Monday, May 30, 2011

Low-dose aspirin is predominantly of value in reducing atherosclerotic events in patients with less advanced diabetes.

Naltrexone/Bupropion Combo Increases Women's Weight Loss

Posted: Monday, May 23, 2011

Two phase 3 studies have found that a combination of naltrexone SR/bupropion SR can produce significant weight loss in overweight and obese women, regardless of menopausal status.

FDA Approves New DPP-IV Inhibitor: Tradjenta (Linagliptin)

Posted: Sunday, May 08, 2011

A new prescription medication Tradjenta (linagliptin) has gained FDA approval for the treatment of adult Type 2 diabetes. Tradjenta will compete with two other drugs in the same family, Onglyza and Januvia.

ProtoKinetix Forms Joint Venture Partnership to Launch a Dermatitis Therapeutic Product for the Skin Care Industry

Posted: Wednesday, April 27, 2011

Upon completion of this formulation, the Joint Venture will be able to offer a topical preparation to specifically address skin conditions caused by inflammation. Conditions such as dermatitis, psoriasis and eczema are often treated with applications of corticosteroids or immune modulators, both of which carry inherent, long term health risks.

“This Joint Venture supports ProtoKinetix’ pursuit of AAGP™ products for markets looking for safe and effective solutions to diseases and conditions caused by chronic inflammation and immune response deficiencies”.